Wellington Management Group
ALXO icon

Wellington Management Group’s ALX Oncology ALXO Stock Holding History

Wellington Management Group’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-167,831
Closed -$305K – 1936
2024
Q3 		$305K Buy
167,831
+22,114
+15% +$82.2K ﹤0.01% 1867
2024
Q2 		$879K Buy
145,717
+18,680
+15% +$230K ﹤0.01% 1700
2024
Q1 		$1.42M Buy
127,037
+46,349
+57% +$651K ﹤0.01% 1602
2023
Q4 		$1.2M Buy
+80,688
New +$766K ﹤0.01% 1593
2022
Q4 		– Sell
-47,586
Closed -$455K – 1983
2022
Q3 		$455K Sell
47,586
-1,080,515
-96% -$12.6M ﹤0.01% 1820
2022
Q2 		$9.13M Sell
1,128,101
-1,681,725
-60% -$18.3M ﹤0.01% 1148
2022
Q1 		$47.5M Sell
2,809,826
-918,504
-25% -$15.7M 0.01% 770
2021
Q4 		$80.1M Sell
3,728,330
-138,812
-4% -$5.99M 0.01% 691
2021
Q3 		$286M Buy
3,867,142
+970,252
+33% +$64.7M 0.05% 356
2021
Q2 		$158M Buy
2,896,890
+235,328
+9% +$14.1M 0.03% 505
2021
Q1 		$196M Buy
2,661,562
+678,456
+34% +$53.4M 0.03% 429
2020
Q4 		$171M Buy
1,983,106
+948,578
+92% +$57.1M 0.03% 448
2020
Q3 		$39M Buy
+1,034,528
New +$40.7M 0.01% 762

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Wellington Management Group's ALXO Position: Q4 2024 in Review

Wellington Management Group sold out of ALX Oncology (ALXO) in Q4 2024, closing a stake of 167,831 shares — an estimated $305K sold.

Wellington Management Group first reported a position in ALXO in Q3 2020 and held it in 13 quarters. The position peaked at $286M in Q3 2021. 87 funds tracked by Wall St. Rank hold ALXO as of Q4 2024.

  • Wellington Management Group reported no remaining ALX Oncology position as of Q4 2024 after selling out during the quarter.
  • Wellington Management Group sold 167,831 ALX Oncology shares in Q4 2024, an estimated $305K.
  • Wellington Management Group first reported a position in ALX Oncology in Q3 2020 and held it in 13 quarters.
  • Wellington Management Group's ALX Oncology position peaked at $286M in Q3 2021.
  • 87 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2024.

Based on Wellington Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.